Ilex acquires Symphar for $30M

ILXO acquired Symphar, a Geneva-based medicinal chemistry company, for $15 million in stock and $15 million in cash. The acquisition gives ILXO full ownership of Apomine (SR-45023A), an oral bisphosph...